To print: Select File and then Print from your browser's menu --------------------------------------------------------------------------------------- Title: Vectavir Launched in the U.K. as a New Treatment for Herpes Labialis URL: http://www.pslgroup.com/dg/93C6.htm Doctor's Guide June 4, 1996
LONDON, June 4, 1996 -- A new prescription treatment for herpes labialis (cold sores) was launched in the United Kingdom today by SmithKline Beecham (NYSE: SBH), the company said. Vectavir, penciclovir 1% cream, has been shown in the largest clinical trial of topical antivirals undertaken to date to significantly reduce the time to loss of lesions and loss of lesion pain. Vectavir is the first topical antiviral to show clinical benefit in both early and late treatment stages. The launch of Vectavir is timely. A recent survey of general practitioners in the United Kingdom found that patients with cold sores often present too late for effective treatment with existing agents. Physicians perceive a great need for a product which is effective for early and late stages of the development of a cold sore. "In the UK, approximately one quarter of the adult population suffers from cold sores, on average twice a year," Dr Michael Lewis, University of Wales College of Medicine, Cardiff, said. "Many clinicians are aware of the distress caused to patients by cold sores and they are aware that by the time the patient gets to them it is too late to treat with existing antiviral agents. These new data are important in that treatment can now be started at a later stage." Penciclovir is currently under review by regulatory authorities in other major countries including the U.S. Food and Drug Administration. SmithKline Beecham (NYSE: SBH) -- one of the world's leading healthcare companies -- discovers, develops, manufactures, and markets pharmaceuticals, vaccines, over-the-counter medicines, and health- related consumer products, and provides healthcare services including clinical laboratory testing, disease management, and pharmaceutical benefit management.f --------------------------------------------------------------------------------------------- Copyright © 1999 P\S\L Consulting Group Inc. All rights reserved. Republication or redistribution of P\S\L content is expressly prohibited without the prior written consent of P\S\L. P\S\L shall not be liable for any errors, omissions or delays in this content or any other content on its sites, newsletters or other publications, nor for any decisions or actions taken in reliance on such content. --------------------------------------------------------------------------------------------- This news story was printed from *Doctor's Guide to the Internet* located at http://www.docguide.com --------------------------------------------------------------------------------------- Return to News Story Page This site is maintained by webmaster@pslgroup.com Please contact us with any comments, problems or bugs. All contents Copyright (c) 1998 P\S\L Consulting Group Inc. All rights reserved.